drugset / Trial / NCT01814085
A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of escitalopram treatment in participants with severe major depressive disorder (MDD \[marked depression appearing in the involution period and characterized by hallucinations, delusions, paranoia, and agitation\]).
Timeline
- Start
- 2010-02
- Primary completion
- 2012-02
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Escitalopram | Small molecule | 10 mg | Oral |
| Subject | Escitalopram | Small molecule | 20 mg | Oral |